• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
Are GSK shares a bargain after falling 11%? Motley Fool (UK)12:47 14-Jun-24
In the last 7 days
GSK acquires Elsie Biotechnologies for oligonucleotide therapy Chemical & Engineering News23:49 13-Jun-24
GSK and Ochre Bio link to explore liver disease drivers Pharmaceutical Technology12:13 13-Jun-24
REGENXBIO Announces Leadership Transition PR Newswire (Press Release)12:07 12-Jun-24
GSK Gets RSV Vaccine Expansion To Younger Adults Scrip Pharma Intelligence17:33 11-Jun-24
GSK, M&G, Qinetiq: What brokers said today Proactive Investors (UK)15:53 11-Jun-24
Anaemia drug accepted for use within NHS Scotland Pharmaceutical Field11:34 11-Jun-24
GSK 'still appealing' despite US legal setback says broker Proactive Investors (UK)09:37 11-Jun-24
GSK appeals Delaware Zantac ruling Proactive Investors (UK)08:16 11-Jun-24
GSK welcomes dismissal of Zantac case in Illinois London South East19:04 10-Jun-24
Statement: Zantac (ranitidine) litigation – Kasza case GlaxoSmithKline (Press Release)18:44 10-Jun-24
GSK closes US$50m acquisition with Elsie Biotechnologies Inc European Biotechnology News11:47 10-Jun-24
US FDA Approves Expanded Age Indication For GSK’s Arexvy European Pharmaceutical Manufacturer10:28 10-Jun-24
GSK RSV jab receives label expansion from US regulator Proactive Investors (UK)08:21 10-Jun-24
GSK's Arexvy vaccine approved for wider age range London South East07:32 10-Jun-24
In the last month
GSK acquires Elsie to unlock oligonucleotide therapeutics Pharmaceutical Technology11:18 7-Jun-24
Stockwatch: is this an existential crisis for GSK? interactive investor09:10 6-Jun-24
GSK shares fall 9% in wake of Zantac court ruling Pharmaceutical Technology14:31 4-Jun-24
BT, Anglo American, GSK and more: What brokers said today Proactive Investors (UK)15:42 3-Jun-24
view more headlines
14 Jun 12:47

GlaxoSmithKline News

NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
Read more

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.